Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

Sci Rep. 2020 Nov 2;10(1):19248. doi: 10.1038/s41598-020-76385-8.

¹ Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
² Department of Oncology, Hospices Civils de Lyon, Université Lyon 1, Lyon, France.
³ Department of Biostatistics, Hospices Civils de Lyon, CNRSUMR 5558, Lyon, France.
⁴ Laboratoire de Biométrie Et Biologie Evolutive, Equipe Biostatistique-Santé, 69100, Villeurbanne, France.
⁵ Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
⁶ Department of Genetic Medicine, Laboratory and Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
⁷ Department of Biopathology, Centre Léon Bérard, Lyon, France.
⁸ Department of Diagnostics, Division of Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
⁹ Department of Genetics, Hospices Civils de Lyon, Lyon, France.
¹⁰ Unit of Prevention and Genetic Epidemiology, UMR CNRS 5558, Centre Léon Bérard, Lyon, France.
¹¹ Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland. intidhar.labidi-galy@hcuge.ch.
¹² Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland. intidhar.labidi-galy@hcuge.ch.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.